Takeda's Alogliptin Suffers Major Setback, Delaying Drug Launch Until 2012 Or Later

Negative news increases pressure on Japanese pharma's oncology subsidiary Millennium Pharmaceuticals to perform.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet